NFKB1 and acute myeloid leukemia: While NF-κB activity is undetectable in unstimulated normal CD34+ hematopoietic stem/progenitor cells (HSPCs), it is constitutively activated in CD34+CD38- LSCs isolated from almost all AML patients [12–14].